Long-Term Follow-up Safety of Clonidine Micropellets
Long-Term Follow-up Safety of Clonidine Micropellets
Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months
 post injection.
Inclusion Criteria:

 -  Subject who have successfully completed all STX-015-18-01 study related activities,
 are reconfirmed to be eligible and have signed informed consent to participate.

 Exclusion Criteria:

 -  Subjects who, in the opinion of the investigator, have demonstrated significant
 non-compliance with STX-015-18-01 study procedures.

 -  Subjects who were unblinded to their treatment in STX-015-18-01 study.